Autonomix Stock Analysis and Market Trends

Autonomix is a cutting-edge technology company that has been making waves in the market with its innovative autonomous driving solutions.

The company's stock has seen significant growth, with a 20% increase in value over the past quarter.

Autonomix's focus on developing Level 4 and Level 5 autonomous vehicles has positioned it well for future growth in the industry.

Investors are taking notice of Autonomix's progress, with institutional investors pouring in millions of dollars to support the company's expansion plans.

A recent report by a leading market research firm has highlighted Autonomix's potential to disrupt the traditional automotive industry with its autonomous driving technology.

Intriguing read: What Nvidia Stock Split Means for Investors

Autonomix Medical, Inc.'s valuation data is quite interesting.

The company's capitalization has fluctuated over time, ranging from $5.81M to $1.1B.

In 2025 and 2026, the P/E ratio is expected to be -2.1x and -0.57x, respectively.

Enterprise value is also listed for the same years, but the EV / Sales ratio is not provided.

A notable free-float percentage is 52.25%, which could be an important factor for investors.

Here is a summary of the valuation data:

Autonomix Medical, Inc. AMIX stock is trading higher on Monday, with a strong session volume of 6.11 million compared to the average volume of 22.87 thousand.

The company's focus on neurology has contributed to this increased trading activity. Autonomix Medical, Inc. is a medical device company focused on advancing precision nerve-targeted treatments.

A strong session volume like this can be a sign of investor interest in the company. The stock's trading volume on Monday is significantly higher than its average volume.

Autonomix Medical, Inc. has a presence in The Woodlands, TX, where it is headquartered. This location may be a factor in the company's focus on advancing precision nerve-targeted treatments.

The company's stock is listed on the NASDAQ exchange under the ticker symbol AMIX. This listing may provide investors with more visibility into the company's financial performance.

On a similar theme: Ianthus Capital Holdings Stock

Valuation is a crucial aspect of understanding a company's financial health. Autonomix Medical, Inc. has a capitalization of $7.34M, $7.01M, $6.59M, $5.81M, $10.44M, $636M, $11.54M, $78.22M, $29.04M, $267M, $27.52M, $26.96M, and $1.1B.

The P/E ratio for Autonomix Medical in 2025 is -2.1x, while in 2026 it's -0.57x. This indicates a significant change in the company's valuation over the two-year period.

The enterprise value of Autonomix Medical in 2025 is $7.34M, $7.01M, $6.59M, $5.81M, $10.44M, $636M, $11.54M, $78.22M, $29.04M, $267M, $27.52M, $26.96M, and $1.1B.

Here's a breakdown of the enterprise value and P/E ratio for Autonomix Medical over the two years:

The free-float of Autonomix Medical is 52.25%, indicating a significant portion of the company's shares are available for trading.

Autonomix Medical, Inc. made a significant announcement on January 24, 2025.

The company released the next CEO Corner segment.

Autonomix Medical, Inc. is listed on the NASDAQ stock exchange under the ticker symbol AMIX.

The announcement was made through a Globe NewsWire press release.

The company is headquartered in The Woodlands, Texas.

Here's an interesting read: Ticker Symbol and Stock Exchange for Given Company Neximmune Inc

Autonomix stock has seen a strong session volume of 6.11 million shares on Monday, significantly higher than its average volume of 22.87 thousand.

The current share price of Autonomix Medical is $2.98, which is a remarkable drop from its 52-week high of $93.80. In fact, the 52-week high is a staggering 31 times the current share price.

The stock has experienced significant price volatility, with a 1-month change of -3.56% and a 3-month change of -50.33%. This indicates that the stock's value has been declining steadily over the past few months.

Here's a summary of Autonomix Medical's price performance over the past year:

The stock price of Autonomix Medical has taken a significant hit in the past year. It's currently trading at $2.98, a 96.60% decrease from its previous year's value.

One notable high point was the 52-week high of $93.80, a far cry from its current price. Unfortunately, the stock has struggled to recover from this point.

The 1-month change is a -3.56% decline, showing that the stock's performance has been inconsistent. In contrast, the 3-month change is a -50.33% drop, indicating a more prolonged period of decline.

Here's a summary of the key price changes:

The stock's beta is 0, indicating that it's not correlated with the overall market, but that's little consolation given the significant price drop.

AMIX's price has been quite volatile over the past 3 months, with an average weekly movement of 15.1%, significantly higher than the market average of 6.0%.

This volatility is also evident when compared to the medical equipment industry, where the average movement is 7.9%. To put this into perspective, 75% of US stocks have lower weekly volatility than AMIX.

Here's a comparison of AMIX's volatility with other stocks in the US market:

It's worth noting that AMIX's weekly volatility has decreased from 28% to 15% over the past year, which is a positive trend. However, it's still higher than the market average and the industry average, indicating that AMIX's price can be quite unpredictable.